Inhibikase Therapeutics
Price & Volume
Stats
See more52W Range | $1.33-$3.32 |
Market Cap | $119.2M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $1 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$27.1M |
Diluted EPS | -$0.04 |
News
See moreYahoo Finance • 2 months ago
Inhibikase Therapeutics sells 68.97M shares and pre-funded warrants at $1.45/share
Yahoo Finance • 2 months ago
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
Yahoo Finance • 2 months ago
Inhibikase Therapeutics announces proposed public offering and pre-funded warrants
Yahoo Finance • 2 months ago
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
About
CEO | Mr. Mark T. Iwicki |
Address | 3350 Riverwood Parkway SE, Atlanta, GA, United States, 30339 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |
